Qsymia
These highlights do not include all the information needed to use QSYMIA safely and effectively. See full prescribing information for QSYMIA. QSYMIA (phentermine and topiramate extended-release capsules), for oral use, CIV Initial U.S. Approval: 2012
40dd5602-53da-45ac-bb4b-15789aba40f9
HUMAN PRESCRIPTION DRUG LABEL
Dec 11, 2023
Vivus LLC
DUNS: 782772263
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
phentermine and topiramate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
phentermine and topiramate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
phentermine and topiramate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
phentermine and topiramate
Product Details
FDA regulatory identification and product classification information